Mohammad Newaz
Impact in
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
- Antioxidant Activity and Oxidative Stress
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
- Physiology 13
- Nitric Oxide and Endothelin Effects 12
-
- Peroxisome Proliferator-Activated Receptors 5
- Co-authors
- Adebayo Oyekan (15 shared papers)Zivar Yousefipour (19 shared papers)Kasturi Ranganna (3 shared papers)Shirlette G. Milton (2 shared papers)Luan D. Truong (4 shared papers)Richard J. Johnson (1 shared paper)Wei Mu (1 shared paper)David A. Long (1 shared paper)
- Journals
- The FASEB Journal (4 papers)Renal Failure (3 papers)Journal of Cardiovascular Pharmacology (3 papers)Clinical and Experimental Hypertension (3 papers)Journal of Hypertension (2 papers)
- Partner nations
- United StatesMalaysiaPhilippines
In The Last Decade
Mohammad Newaz
33 papers receiving 559 citations
Peers
Comparison fields: 5 of 80
- Biochemistry 68
- Biochemistry 73
- Nephrology 60
- Physiology 149
- Nutrition and Dietetics 77
Countries citing papers authored by Mohammad Newaz
This map shows the geographic impact of Mohammad Newaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Newaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Newaz more than expected).
Fields of papers citing papers by Mohammad Newaz
This network shows the impact of papers produced by Mohammad Newaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Newaz. The network helps show where Mohammad Newaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Newaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 61 | |
| 2 | 2004 | 60 | |
| 3 | 2005 | 52 | |
| 4 | Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gamma-tocotrienol. | 2003 | 50 |
| 5 | 2005 | 45 | |
| 6 | Mechanism of acrolein-induced vascular toxicity. | 2005 | 45 |
| 7 | 2006 | 44 | |
| 8 | 1996 | 29 | |
| 9 | 2010 | 24 | |
| 10 | 2005 | 24 | |
| 11 | 2001 | 16 | |
| 12 | 2014 | 15 | |
| 13 | Detection of xanthine oxidase in human plasma. | 1998 | 15 |
| 14 | 2007 | 13 | |
| 15 | 2003 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2003 | 8 | |
| 18 | 2002 | 8 | |
| 19 | 2003 | 7 | |
| 20 | 2009 | 7 |
About Mohammad Newaz
Mohammad Newaz is a scholar working on Physiology, Molecular Biology, Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 34 papers that have together received 579 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (12 papers), Eicosanoids and Hypertension Pharmacology (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Renin-Angiotensin System Studies (3 papers), Antioxidant Activity and Oxidative Stress (3 papers), Alcohol Consumption and Health Effects (3 papers) and Blood Pressure and Hypertension Studies (2 papers). The work is most often cited by research in Biochemistry (68 citations), Biochemistry (73 citations), Nephrology (60 citations), Physiology (149 citations) and Nutrition and Dietetics (77 citations). Mohammad Newaz has collaborated with scholars based in United States, Malaysia and Philippines. Frequent co-authors include Adebayo Oyekan, Zivar Yousefipour, Kasturi Ranganna, Shirlette G. Milton, Luan D. Truong, Richard J. Johnson, Wei Mu, David A. Long, Sharma Prabhakar and Karen Price. Their work appears in journals such as The FASEB Journal, Renal Failure, Journal of Cardiovascular Pharmacology, Clinical and Experimental Hypertension and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.